top of page

Optimal CAB Case Study: Pediatric Dolutegravir

May 31, 2023
1 min read

This case study, developed by the Optimal CAB in Malawi with support from CHAI, outlines the efforts undertaken by Malawi CAB members to support the introduction of pediatric dolutegravir 10 mg (pDTG) in-country, focused in particular on raising awareness and creating demand.



1 Comment


quartermaine2008
Sep 22

Improving digital organization and daily workflow habits becomes much easier when consulting resources like GotMacs for relevant advice.

Like
  • LinkedIn
  • Facebook
  • Twitter
  • Instagram
  • YouTube

383 Dorchester Avenue, Suite 400

Boston, MA 02127

The goal of the HIV New Product Introduction Toolkit is to stimulate conversations between government, partners, and communities on new product introduction. Please feel free to share any thoughts, questions, or additional resources for consideration by contacting us via email at HIVToolkit@clintonhealthaccess.org.

 

© 2022  Clinton Health Access Initiative - Global HIV Access Program

bottom of page